Literature DB >> 1701824

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.

H H Jabara1, S M Fu, R S Geha, D Vercelli.   

Abstract

A novel pathway of IgE-B cell differentiation has been identified. Engagement of the B cell antigen CD40 by F(ab')2 fragments of monoclonal antibody (mAb) 626.1 in the presence of recombinant interleukin 4 (rIL-4) induced intense IgE synthesis, but modest IgG synthesis, by highly purified human B cells. Surface IgE- B cells isolated by cell sorting were induced to produce IgE by mAb 626.1 and IL-4. Thus, IgE synthesis is unlikely to result from expansion of a B cell population precommitted to IgE in vivo. A neutralizing anti-IL-6 antibody strongly, but not completely, inhibited the IgE response. This indicates that autocrine production of IL-6 plays an important amplification role in IgE synthesis triggered by anti-CD40 mAb and IL-4. Although the exact role played by CD40 in IgE responses in vivo remains to be established, this T cell-independent system represents a useful model to characterize the biochemical and molecular events leading to IgE synthesis in human B cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701824      PMCID: PMC2188752          DOI: 10.1084/jem.172.6.1861

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

Review 1.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

2.  Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation.

Authors:  M C Raynal; Z Y Liu; T Hirano; L Mayer; T Kishimoto; S Chen-Kiang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Structure and expression of murine germ-line immunoglobulin epsilon heavy chain transcripts induced by interleukin 4.

Authors:  S Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.

Authors:  M F Gruber; J M Bjorndahl; S Nakamura; S M Fu
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

5.  Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis.

Authors:  D Vercelli; H H Jabara; K Arai; T Yokota; R S Geha
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

6.  IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma.

Authors:  G Thyphronitis; G C Tsokos; C H June; A D Levine; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.

Authors:  E A Clark; G L Shu; B Lüscher; K E Draves; J Banchereau; J A Ledbetter; M A Valentine
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

8.  Clonal and molecular characteristics of the human IgE-committed B cell subset.

Authors:  T MacKenzie; H M Dosch
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

9.  Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes.

Authors:  E B Smeland; H K Blomhoff; S Funderud; M R Shalaby; T Espevik
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens.

Authors:  D Vercelli; H H Jabara; K Arai; R S Geha
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  99 in total

Review 1.  IgE in asthma and atopy: cellular and molecular connections.

Authors:  H C Oettgen; R S Geha
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Pollution and the immune response: atopic diseases--are we too dirty or too clean?

Authors:  D Diaz-Sanchez
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

3.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

Authors:  R J Noelle; M Roy; D M Shepherd; I Stamenkovic; J A Ledbetter; A Aruffo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients.

Authors:  Samuele E Burastero; Clara Paolucci; Daniela Breda; Armando Soldarini; Fernanda Dorigatti; Elisa Soprana; Hamid Hasson; Priscilla Biswas; Adriano Lazzarin; Antonella Castagna
Journal:  J Clin Immunol       Date:  2006-04-07       Impact factor: 8.317

5.  Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes.

Authors:  J B Splawski; P E Lipsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 6.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

7.  TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.

Authors:  Haifa H Jabara; Yu Weng; Tatyana Sannikova; Raif S Geha
Journal:  Int Immunol       Date:  2009-02-19       Impact factor: 4.823

8.  Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.

Authors:  N Tsukamoto; N Kobayashi; S Azuma; T Yamamoto; J Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Inhibition of LFA-1-dependent human B-cell aggregation induced by CD40 antibodies and interleukin-4 leads to decreased IgE synthesis.

Authors:  P Björck; S Paulie
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

10.  Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.

Authors:  C Scheid; R Young; R McDermott; L Fitzsimmons; J H Scarffe; P L Stern
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.